Clinical Trials Logo

Filter by:
NCT ID: NCT02408055 Completed - Dyslipidemia Clinical Trials

ADME Study in Healthy Male Subjects With TA-8995

Start date: June 2015
Phase: Phase 1
Study type: Interventional

A study to measure the absorption, metabolism and excretion of a single dose of radiolabelled TA-8995 (10mg) in healthy male subjects.

NCT ID: NCT02407756 Completed - Atopic Dermatitis Clinical Trials

A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)

Start date: March 31, 2015
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis (AD) (for adolescents ≥12 to <18 years of age) or severe AD (for children ≥6 to <12 years of age). The secondary objective of the study is to explore the immunogenicity and efficacy of dupilumab in pediatric patients with moderate-to-severe AD (for adolescents ≥12 to <18 years of age) or severe AD (for children ≥6 to <12 years of age).

NCT ID: NCT02407678 Completed - Choroideremia Clinical Trials

REP1 Gene Replacement Therapy for Choroideremia

REGENERATE
Start date: August 16, 2016
Phase: Phase 2
Study type: Interventional

The assessment of the efficacy (with respect to preservation of visual function and retinal structure) and safety of a single subretinal injection of AAV2.REP1 in participants with a confirmed diagnosis of choroideremia, as evaluated by various functional and anatomical outcomes measured over a number of time points up to 24 months post-treatment.

NCT ID: NCT02407236 Completed - Clinical trials for Inflammatory Bowel Diseases

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

UNIFI
Start date: July 10, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of ustekinumab as intravenous (IV: into the vein) infusion in induction study in participants with moderately to severely active Ulcerative Colitis (UC) and as subcutaneous (SC) administration in maintenance study in participants with moderately to severely active Ulcerative Colitis (UC) who have demonstrated a clinical response to Induction treatment with IV ustekinumab.

NCT ID: NCT02407197 Completed - Clinical trials for Coronary Artery Disease

International T1 Multicentre CMR Outcome Study

T1-CMR
Start date: January 2011
Phase:
Study type: Observational [Patient Registry]

Myocardial fibrosis is the fundamental substrate for the development of heart failure. Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping. Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy. Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE. Primary endpoints: all cause and cardiovascular mortality. Secondary endpoints: arrhythmic composite and HF composite endpoints.

NCT ID: NCT02407145 Completed - Clinical trials for Urinary Stress Incontinence

Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women

Start date: March 2016
Phase:
Study type: Observational

This study is designed to evaluate the safety and efficacy of low elasticity polyvinylidene fluoride (DynaMesh®-SIS soft) retropubic tension-free midurethral slings in the treatment of stress urinary incontinence in women. Women who are having a retropubic PVDF midurethral sling for urodynamic stress incontinence will be followed up for 24 months to address its efficacy and rate of complications.

NCT ID: NCT02407015 Completed - Visual Fatigue Clinical Trials

The Effect of 3D Autostereoscopic Video-game Play on the Visual Fatigue in Children

Start date: December 2014
Phase: N/A
Study type: Interventional

This study aims to examine the specific effect that 3D game play has on the control of the eyes horizontal movements. It will examine the youngest group of consumers this technology is marketed to, 7 to 11-year-olds and no children under 7 years of age will be recruited to this study as per Nintendo's hardware guidelines, which recommends that children under 7 years of age not play in 3D mode. It will examine the effect of playing in 3D for 30 minutes on horizontal fusional amplitudes compared with a control group playing in 2D for 30 minutes.

NCT ID: NCT02406456 Completed - Alcohol Abuse Clinical Trials

Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders

Start date: March 2015
Phase: N/A
Study type: Interventional

Participants will undergo a single session of functional magnetic resonance imaging (fMRI)-based neurofeedback (approximately 1 hour). The investigators will assess their ability to regulate motivational networks of the brain during the exposure to alcohol cues and evaluate immediate effects on craving and cognitive bias for alcohol by administering a questionnaire and a Stroop task before and after the session.

NCT ID: NCT02405494 Completed - Appetite Clinical Trials

Effect of Liquid Volume and the Amount of Incorporated Gas Into a Carbohydrate/Protein Beverage on Satiety

Start date: February 2011
Phase: N/A
Study type: Interventional

Liquid foams can be formed by trapping pockets of gas in a beverage. The primary objective of this study is to test the individual contribution, and possible interaction, of the liquid volume and gas to liquid volume ratio (i.e. %overrun (%OR, defined as 100 x [gas volume/liquid volume]) of a beverage to its satiating properties.

NCT ID: NCT02404831 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

An Evaluation of Web Based Pulmonary Rehabilitation

webbasedPR
Start date: April 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this pilot study is to compare a six week web-based pulmonary rehabilitation programme with traditional hospital-based pulmonary rehabilitation classes for people affected by COPD.